Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Urology

• Publication date

  2005-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.JU.0000151994.12709.12PMID 15711280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging.

  2002cited by this paper

• Akkermansia muciniphila Metabolite Inosine Inhibits Castration Resistance in Prostate Cancer

  2024cites this paper
• Midlife baseline prostate‐specific antigen, velocity, and doubling time association with lethal prostate cancer and mortality

  2024cites this paper
• Systematic Review of Preoperative Prognostic Biomarkers in Perihilar Cholangiocarcinoma

  2024cites this paper
• Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer

  2023cites this paper
• Physical Examination Discovered Prostate Cancer Metastasis to the Testis: A Case Report

  2022cites this paper
• Impact of Gleason score of the tumor at the positive surgical margin as a prognostic factor

  2022cites this paper
• NCCN Clinical Practice Guidelines in Oncology ( NCCN Guidelines ® ) Prostate Cancer Early Detection Version 1 . 2022 —

  2022cites this paper
• Changes in prostate-specific antigen kinetics during androgen-deprivation therapy as a predictor of response to abiraterone in chemonaïve patients with metastatic castration-resistant prostate cancer

  2022cites this paper
• Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine

  2021cites this paper
• 68Ga-PSMA11 PET/CT for biochemically recurrent prostate cancer: Influence of dual-time and PMT- vs SiPM-based detectors

  2021cites this paper
• Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - a systematic review

  2020cites this paper
• Running title: The role of miR-125a-5p and miR-141-5p in PC Plasma exosomal miR-125a-5p and miR-141-5p as non-invasive biomarkers for prostate cancer

  2020cites this paper
• Impact of surgical technique and surgeon variability on functional and oncologic outcomes

  2020cites this paper
• Evaluation of heterogeneous factors of low-grade prostate cancer in patients before and after radical prostatectomy

  2020cites this paper
• Is There any Relationship between Age of Patients and Prostate Cancer Aggressiveness?

  2020cites this paper
• Plasma exosomal miR-125a-5p and miR-141-5p as non-invasive biomarkers for prostate cancer.

  2020cites this paper
• miR-19a promotes the metastasis and EMT through CUL5 in prostate cancer cell line PC3.

  2020cites this paper
• Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma

  2019cites this paper
• Elevated Expression of EPHA2 Is Associated With Poor Prognosis After Radical Prostatectomy in Prostate Cancer

  2019cites this paper
• Low-molecular-weight Protein Tyrosine Phosphatase Is a Possible Biomarker for Predicting Postoperative Biochemical Recurrence in Prostate Cancer With Negative Surgical Margins

  2019cites this paper
• Prostate cancer and the role of biomarkers

  2019cites this paper
• The dose distribution in dominant intraprostatic tumour lesions defined by multiparametric MRI and PSMA PET/CT correlates with the outcome in patients treated with primary radiation therapy for prostate cancer

  2018cites this paper
• UNIVERSITY OF SPLIT SCHOOL OF MEDICINE Sebastian Radosevic SALVAGE RADIOTHERAPY OF PROSTATE CANCER. RETROSPECTIVE ANALYSIS OF 10 YEARS’ EXPERIENCE IN THE DEPARMENT OF ONCOLOGY AND RADIOTHERAPY UNIVERSITY HOSPITAL OF SPLIT DIPLOMA THESIS Academic year: 2017/2018 Mentor: Assist. Prof. Tomislav Omrčen

  2018cites this paper
• Predictive factors of biochemical recurrence after radical prostatectomy for high‐risk prostate cancer

  2018cites this paper
• Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

  2018cites this paper
• Prostate Cancer Screening: Outcomes and Risk Prediction

  2018cites this paper
• PrOsTaTe CanCer DiaGnOsis UsinG MaGneTiC resOnanCe iMaGinG – a MaCHine LearninG aPPrOaCH

  2018cites this paper
• Prognostic indicators of outcome for patients with skeletal metastases from carcinoma of the prostate

  2018cites this paper
• Indications for and transitioning to secondary treatment while on active surveillance for prostate cancer

  2018cites this paper
• High-intensity focused ultrasound for the treatment of prostate cancer. 1st Update 2018

  2018cites this paper
• Identification of the genetic alterations in prostate cancer metastases

  2017cites this paper
• Beyond the PSA test: How to better stratify a patient's risk of prostate cancer.

  2017cites this paper
• Oncologic Outcomes of Definitive Treatments for Low‐ and Intermediate‐Risk Prostate Cancer After a Period of Active Surveillance

  2017cites this paper
• Radical Prostatectomy in High Risk Prostate Cancer 135 risk prostate cancer

  2017cites this paper
• RAZINA INICIJALNOG PROSTATIČNOG SPECIFIČNOG ANTIGENA I HISTOLOŠKI GRADUS KARCINOMA PROSTATE U BIOPTIČKIM UZORCIMA BOLESNIKA LIJEČENIH U KLINIČKOM BOLNIČKOM CENTRU SPLIT TIJEKOM 2016. GODINE

  2017cites this paper
• Prostatic Specific Antigen Less then 10 ng/mL in the Diagnostic and Surveillance of Prostate Cancer

  2017cites this paper
• Oncological and functional outcomes 1 year after radical prostatectomy for very‐low‐risk prostate cancer: results from the prospective LAPPRO trial

  2016cites this paper
• The Quantitative Criteria Based on the Fractal Dimensions, Entropy, and Lacunarity for the Spatial Distribution of Cancer Cell Nuclei Enable Identification of Low or High Aggressive Prostate Carcinomas

  2016cites this paper
• PSA and beyond: alternative prostate cancer biomarkers

  2016cites this paper
• Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate Cancer

  2016cites this paper
• Total and Free PSA, PCA3, PSA Density and Velocity

  2016cites this paper
• Prostate-specific Antigen Density Variation Rate as a Potential Guideline Parameter for Second Prostate Cancer Detection Biopsy

  2016cites this paper
• First off‐time treatment prostate‐specific antigen kinetics predicts survival in intermittent androgen deprivation for prostate cancer

  2016cites this paper
• NCCN Clinical Practice Guidelines in Oncology ( NCCN Guidelines ® ) Prostate Cancer Early Detection

  2016cites this paper
• Active Surveillance for Prostate Cancer

  2016cites this paper
• Association of vitamin D receptor variants with clinical parameters in prostate cancer

  2016cites this paper
• Aceptación y resultados de la aplicación en España de un protocolo de vigilancia activa en cáncer de próstata

  2016cites this paper
• Novel biomarkers for the detection of prostate cancer

  2016cites this paper
• The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP)

  2015cites this paper
• NCCN Guidelines Version 2 . 2017 Table of Contents Prostate Cancer Early Detection

  2015cites this paper
• Association of time to prostate-specific antigen nadir and logarithm of prostate-specific antigen velocity after progression in metastatic prostate cancer with prior primary androgen deprivation therapy

  2015cites this paper
• Relationships between times to testosterone and prostate-specific antigen rises during the first off-treatment interval of intermittent androgen deprivation are prognostic for castration resistance in men with nonmetastatic prostate cancer.

  2015cites this paper
• Advances in Cancer Biomarkers

  2015cites this paper
• Prostate cancer cell-derived exosomes enable androgen production by patients derived stem cells: Exploring racial disparity and targeting residual androgen through stem cell-based selective delivery of 3alpha-HSD

  2015cites this paper
• The Risks and Benefits of Current Treatment Options for Prostate Cancer and Future Possibilities in Advanced Imaging and Targeted Therapy: A Review

  2015cites this paper
• Biomarkers for evaluation of prostate cancer prognosis.

  2015cites this paper
• Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?

  2015cites this paper
• Prostate Cancer Early Detection, Version 2.2015

  2015cites this paper
• Radiation Treatment of Lymph Node Recurrence from Prostate Cancer: Is 11C-Choline PET/CT Predictive of Survival Outcomes?

  2015cites this paper
• POSTRADICAL PROSTATECTOMY IRRADIATION IN PROSTATE CANCER

  2014cites this paper
• Sipuleucel-T and immunotherapy in the treatment of prostate cancer

  2014cites this paper
• DNA aptamer-based detection of prostate cancer

  2014cites this paper
• radiotherapy after radical prostatectomy

  2014cites this paper
• Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer

  2014cites this paper
• PSA velocity: a systematic review of clinical applications.

  2014cites this paper
• Postradical Prostatectomy Irradiation in Prostate Cancer

  2014cites this paper
• A Novel Electrochemical Immunosensor for Prostate-Specific Antigen Based on Noncovalent Nanocomposite of Ferrocene Monocarboxylic Acid with Graphene Oxide

  2014influential citation
• Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical Overview

  2014cites this paper
• Impact of race in using PSA velocity to predict for prostate cancer.

  2014cites this paper
• ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer.

  2014cites this paper
• Change in PSA velocity is a predictor of overall survival in men with biochemically-recurrent prostate cancer treated with non-hormonal agents: Combined analysis of four phase-2 trials

  2014cites this paper
• Co-Occurring Gland Angularity in Localized Subgraphs: Predicting Biochemical Recurrence in Intermediate-Risk Prostate Cancer Patients

  2014cites this paper
• Prostate Cancer That Is Within 0.1 mm of the Surgical Margin of a Radical Prostatectomy Predicts Greater Likelihood of Recurrence

  2014cites this paper
• Immunochromatographic Diagnostic Test Analysis Using Google Glass

  2014cites this paper
• Active surveillance criteria for prostate cancer amongst Dutch urologists

  2014cites this paper
• An Inexpensive, Fast and Sensitive Quantitative Lateral Flow Magneto-Immunoassay for Total Prostate Specific Antigen

  2014cites this paper
• Chapter-10 Prostate Cancer

  2014cites this paper
• Contrast-ultrasound dispersion imaging for prostate cancer localization

  2014cites this paper
• The efficacy and safety of docetaxel plus thalidomide vs. docetaxel alone in patients with androgen-independent prostate cancer: a systematic review

  2014cites this paper
• The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate‐risk disease

  2014cites this paper
• Prostate-specific antigen doubling time and response to cabazitaxel in a hormone-resistant metastatic prostate cancer patient

  2014cites this paper
• Evaluation of Prostate-Specific Antigen Isoform p2PSA and Its Derivates, %p2PSA, Prostate Health Index and Prostate Dimension-Adjusted Related Index in the Detection of Prostate Cancer at First Biopsy: An Exploratory, Prospective Study

  2014cites this paper
• radiotherapy after radical prostatectomy

  2014cites this paper
• The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of D

  2014cites this paper
• Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel

  2014cites this paper
• radiotherapy after radical prostatectomy

  2014cites this paper
• Circulating tumor cells in prostate cancer: a better predictor of survival than prostate specific antigen?

  2014cites this paper
• radiotherapy after radical prostatectomy

  2014cites this paper
• Rôle de l’écho-Doppler puissance dans la détection des cancers à bas risque de la prostate ☆

  2013cites this paper
• The dilemma of a rising prostate-specific antigen level after local therapy: what are our options?

  2013cites this paper
• Cua Guideline Methods and Data Collection

  2013cites this paper
• Co-occurring gland tensors in localized cluster graphs: Quantitative histomorphometry for predicting biochemical recurrence for intermediate grade prostate cancer

  2013cites this paper
• Identification of the demographic and clinical factors in determining the effectiveness of robotic-assisted radical prostatectomy

  2013cites this paper
• Very high risk localized prostate cancer: definition and outcomes

  2013cites this paper
• Pomegranate Juice Metabolites, Ellagic Acid and Urolithin A, Synergistically Inhibit Androgen-Independent Prostate Cancer Cell Growth via Distinct Effects on Cell Cycle Control and Apoptosis

  2013cites this paper
• Comprehensive analysis of post‐diagnostic prostate‐specific antigen kinetics as predictor of a prostate cancer progression in active surveillance patients

  2013cites this paper
• Changes in serum prostate‐specific antigen levels and the identification of prostate cancer in a large managed care population

  2013cites this paper
• Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approaches

  2013cites this paper
• ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging, and surveillance.

  2013cites this paper
• Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate

  2013cites this paper